Page last updated: 2024-10-29

imipramine and Breathlessness

imipramine has been researched along with Breathlessness in 1 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research Excerpts

ExcerptRelevanceReference
"To present information about cardiac syndrome X (CSX) including its (a) definition, (b) etiology and pathology, (c) epidemiology, (d) symptomatology, (e) diagnosis, (f) treatment, and (g) prognosis."1.35Chest pain with angiographic clear coronary arteries: A provider's approach to cardiac syndrome X. ( Larsen, W; Mandleco, B, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Larsen, W1
Mandleco, B1

Other Studies

1 other study available for imipramine and Breathlessness

ArticleYear
Chest pain with angiographic clear coronary arteries: A provider's approach to cardiac syndrome X.
    Journal of the American Academy of Nurse Practitioners, 2009, Volume: 21, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Anticholesteremic Agents; Coronary Angiography; Coronary Circulation;

2009